Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Artemisinin-resistant malaria.

White NJ. and Chotivanich K., (2024), Clin Microbiol Rev

Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis.

Fadilah I. et al, (2024), PLoS Med, 21

In-host modeling of dengue virus and non-structural protein 1 and the effects of ivermectin in patients with acute dengue fever.

Ding J. et al, (2024), CPT Pharmacometrics Syst Pharmacol

Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.

Schilling WHK. et al, (2024), PLoS Med, 21

Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV).

Wongnak P. et al, (2024), Lancet Infect Dis, 24, 953 - 963

Lineage-informative microhaplotypes for recurrence classification and spatio-temporal surveillance of Plasmodium vivax malaria parasites.

Siegel SV. et al, (2024), Nat Commun, 15

Transmission-blocking activities of artesunate, chloroquine, and methylene blue on Plasmodium vivax gametocytes.

Chaumeau V. et al, (2024), Antimicrob Agents Chemother

Artemisinin-resistant malaria in Africa demands urgent action.

Dhorda M. et al, (2024), Science, 385, 252 - 254

Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: an individual patient data meta-analysis of two proof of concept trials

Watson JA. et al, (2024)

A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adults.

Hanboonkunupakarn B. et al, (2024), NPJ Vaccines, 9

Phase 2 pilot trial to optimise pharmacometric evaluations in Chagas disease (CHARM: CHAgas disease PharMacometrics)

Cruz CV. et al, (2024), Wellcome Open Research, 9, 342 - 342

Death from diphtheria.

White NJ., (2024), Lancet, 403, 2590 - 2591

Rectal artesunate: lives not saved.

White NJ. et al, (2024), Trans R Soc Trop Med Hyg

Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity inPlasmodium vivaxmalaria: a systematic review and individual patient data meta-analysis

Fadilah I. et al, (2024)

Molecular markers of artemisinin resistance during falciparum malaria elimination in Eastern Myanmar.

Thu AM. et al, (2024), Malar J, 23

Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants.

Wattanakul T. et al, (2024), Nat Commun, 15

Comparison of lumefantrine, mefloquine, and piperaquine concentrations between capillary plasma and venous plasma samples in pregnant women with uncomplicated falciparum and vivax malaria.

Saito M. et al, (2024), Antimicrob Agents Chemother, 68

The relationship between viral clearance rates and disease progression in early symptomatic COVID-19: a systematic review and meta-regression analysis.

Singh S. et al, (2024), J Antimicrob Chemother, 79, 935 - 945

Comparison of WHO versus national COVID-19 therapeutic guidelines across the world: not exactly a perfect match.

Cokljat M. et al, (2024), BMJ Glob Health, 9

Where will rectal artesunate suppositories save lives?

Watson JA. et al, (2024), Lancet, 403, 1137 - 1138

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?